Gen Surg Cases · surgical-critical-care
Blunt polytrauma with hypotension at 50 minutes — activation, ratios, TXA clock, calcium and after-haemostasis vigilance
Fellowship clinical-management station on blunt-haemorrhage damage control resuscitation: ABC triggers, EAST equal-ratio resuscitation, TXA timing gradient, calcium check-and-replace, targeted fibrinogen, prehospital blood hierarchy and early-versus-late VTE vigilance.
On this page
Study tools
Target exams
Management walkthrough
Activate DCR now — physiology plus FAST, scored formally while transfusing. Systolic 80 with tachycardia, positive FAST and pelvic fracture on 2 units meets every clinical trigger layer — score the four ABC variables (penetrating, FAST-positive, systolic 90 or less, pulse 120 or more) while blood runs, because waiting for laboratory coagulation is the error: shocked arrivals show deranged lactate with near-normal clotting values.[32] Resuscitate with equal amounts of red cells, plasma and platelets in the early empiric phase per EAST (protocol OR 0.61, high plasma OR 0.60, high platelets OR 0.44) — quoting PROPPR whole: no mortality difference (12.7 versus 17.0% at 24 hours; 22.4 versus 26.1% at 30 days), fewer exsanguinations (9.2 versus 14.6%), more haemostasis (86 versus 78%), complications equal.[8][5]
TXA 1 g with the first blood — 50 minutes is inside the best window. Dose 1 g loading over 10 minutes then 1 g over 8 hours: all-cause 14.5% versus 16.0%, bleeding death 4.9% versus 5.7%.[16] At 50 minutes he sits inside the within-1-hour band (RR 0.68) and the 90-minute optimum (within aRR 0.64, beyond aRR 1.04) — after 3 hours the same drug carries a harm signal (RR 1.44), so the loading dose runs now, not after theatre or the scanner.[17][18]
Replace calcium by level; ration fibrinogen by level with bleeding; starve the crystalloid. Ionised 0.96 meets verified hypocalcaemia (1.0 or less): plasma-associated lows run 53% versus 36% with survival tied to severe lows — so give calcium under citrate load and recheck each round, stating no fixed dose.[21] Check fibrinogen with the first round and replace documented low-with-bleeding only — never empirically for every activation, because early 3-pool cryoprecipitate changed 28-day death not at all (25.3% versus 26.1%).[28] Cap crystalloid hard: volume among blood recipients raised mortality (HR 1.65), while hypotensive strategy in hospital cut death (6.3 versus 16.3%) — blood first, salt water least, and prehospital blood over crystalloid wherever the chain carries it (NNT near 10).[37][3]
After haemostasis: pelvis, prophylaxis and disposition. Definitive pelvic control (binder to frame per orthopaedics, angioembolisation on blush), rewarming with transfusion-harm vigilance (rate control, one-unit discipline, cross-checks), ICU with surgical and transfusion-medicine input — and VTE prophylaxis from the moment bleeding allows, because 13% of balanced-resuscitation patients develop VTE with pulmonary embolus predominant in the first 72 hours and late events tracking delayed ratio achievement.[41] Re-escalation triggers are written (pressure, lactate, calcium, fibrinogen, respiratory status), not assumed.
References11ShowHide
- [5]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
- [8]Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg, 2017.PMID 28225743
- [16]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
- [17]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
- [18]Ali A, Gruen RL, Bernard SA, et al. Tranexamic Acid Timing and Mortality Impact After Trauma. Ann Emerg Med, 2026.PMID 40751727
- [21]Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg, 2020.PMID 32317575
- [32]Nunez TC, Voskresensky IV, Dossett LA, et al. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma, 2009.PMID 19204506
- [37]Severance AC, Kutcher ME, Taghavi S, et al. Number Needed to Treat Analysis for Ground Prehospital Blood in Hemorrhagic Shock. J Am Coll Surg, 2026.PMID 42599044
- [28]Davenport R, Curry N, Fox EE, et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA, 2023.PMID 37824155
- [41]Myers SP, Brown JB, Leeper CM, et al. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery, 2019.PMID 31230842
- [3]Indorewala Y, Nasef Y, Jayagopi K, et al. Permissive hypotension in adult trauma: A systematic review of outcomes across clinical settings, injury type, and resuscitation strategies. Am J Emerg Med, 2026.PMID 42030689